Gina Hashem, MD, Mph, Ph.D., Ccrc
About Gina Hashem, MD, Mph, Ph.D., Ccrc
Gina Hashem, MD, MPH, Ph.D., CCRC, is an Associate Director at BridgeBio with over 13 years of experience in clinical and pre-clinical research. She has held various roles in renowned organizations, demonstrating expertise in clinical trial management and advanced molecular biology techniques.
Work at BridgeBio
Gina Hashem serves as the Associate Director at BridgeBio, a role she has held since 2022. In this position, she contributes to the company's clinical research initiatives within the San Francisco Bay Area. Her responsibilities include overseeing clinical trial processes and ensuring compliance with regulatory standards.
Education and Expertise
Gina Hashem holds a Ph.D. in Cell Biology from Southern Methodist University, completed between 1989 and 1993. She also earned a Master of Public Health (MPH) from The University of Texas Health Science Center at Houston in 1988. Additionally, she studied Clinical Trial Design and Management at the University of California, Santa Cruz, obtaining a certificate in 2008. Her educational background supports her extensive expertise in clinical and pre-clinical research.
Background in Clinical Research
Gina Hashem has over 13 years of experience in clinical research. She has held various positions, including Clinical Research Coordinator at West Coast Research LLC and Salinas Valley Memorial Healthcare System. Her roles have involved managing clinical trials and coordinating research activities, contributing to her comprehensive understanding of clinical operations.
Professional Experience at Amgen
At Amgen, Gina Hashem worked in multiple capacities, including Clinical Research Study Manager and Senior Manager Global Clinical Program Manager from 2019 to 2022. Her tenure at Amgen involved managing clinical studies and leading global clinical programs, enhancing her skills in clinical trial management and regulatory compliance.
Leadership and Event Management
Gina Hashem chaired the NCC ACRP Event Management, demonstrating her leadership capabilities in organizing professional events. This role highlights her commitment to advancing clinical research practices and fostering collaboration within the research community.